1. Confirmation of hypermetabolism in amyotrophic lateral sclerosis patients: A study versus healthy control. (September 2018) Authors: Fayemendy, P.; Marin, B.; Nicol, M.; Labrunie, A.; Sourisseau, H.; Boirie, Y.; Walrand, S.; Achamrah, N.; Coëffier, M.; Preux, P.M.; Lautrette, G.; Couratier, P.; Desport, J.C.; Jésus, P. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. (1st February 2016) Authors: Marin, B.; Beghi, E.; Vial, C.; Bernard, E.; Lautrette, G.; Clavelou, P.; Guy, N.; Lemasson, G.; Debruxelles, S.; Cintas, P.; Antoine, J. C.; Camdessanche, J. P.; Logroscino, G.; Preux, P. M.; Couratier, P. Journal: European journal of neurology Issue: Volume 23:Number 4(2016:Apr.) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Follow-up and survival after gastrostomy indication in patients with amyotrophic lateral sclerosis. (December 2020) Authors: Fayemendy, P.; Vergonjeanne, M.; Lautrette, G.; Calmel, N.; Sourisseau, H.; Preux, P.M.; Couratier, P.; Desport, J.C.; Jésus, P. Journal: Clinical nutrition ESPEN Issue: Volume 40(2020) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. (22nd November 2017) Authors: Jésus, P.; Fayemendy, P.; Nicol, M.; Lautrette, G.; Sourisseau, H.; Preux, P.‐M.; Desport, J.‐C.; Marin, B.; Couratier, P. Journal: European journal of neurology Issue: Volume 25:Number 1(2018) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MON-PO449: Predictive Factors at Time of Diagnosis for Gastrostomy and Impact on Survival in Patients with Amyotrophic Lateral Sclerosis. (September 2019) Authors: Vergonjeanne, M.; Fayemendy, P.; Marin, B.; Penoty, M.; Lautrette, G.; Sourisseau, H.; Preux, P.M.; Desport, J.C.; Couratier, P.; Jésus, P. Journal: Clinical nutrition Issue: Volume 38(2019)Supplement 1 Page Start: S224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nutritional and metabolic status at diagnosis and survival of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) compared to patients with ALS alone. (December 2020) Authors: Jésus, P.; Fayemendy, P.; Calmel, N.; Sourisseau, H.; Lautrette, G.; Preux, P.M.; Couratier, P.; Desport, J.C. Journal: Clinical nutrition ESPEN Issue: Volume 40(2020) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Population‐based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe – the French register of ALS in Limousin (FRALim register). (9th June 2014) Authors: Marin, B.; Hamidou, B.; Couratier, P.; Nicol, M.; Delzor, A.; Raymondeau, M.; Druet‐Cabanac, M.; Lautrette, G.; Boumediene, F.; Preux, P. M.; the French register of ALS in Limousin (FRALim) Journal: European journal of neurology Issue: Volume 21:Number 10(2014:Oct.) Page Start: 1292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PT03.3: Hypermetabolism is a Deleterious Prognostic Factor in Patients with Amyotrophic Lateral Sclerosis. (September 2017) Authors: Jésusp, P.; Fayemendy, P.; Nicol, M.; Lautrette, G.; Sourisseau, H.; Preux, P.M.; Desport, J.C.; Marin, B.; Couratier, P. Journal: Clinical nutrition Issue: Volume 36(2017)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Resting energy expenditure equations in amyotrophic lateral sclerosis, creation of an ALS-specific equation. (September 2018) Authors: Jésus, P.; Marin, B.; Fayemendy, P.; Nicol, M.; Lautrette, G.; Sourisseau, H.; Preux, P.M.; Couratier, P.; Desport, J.C. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Study of the relevant threshold of resting energy expenditure variation to screen at diagnosis patients with amyotrophic lateral sclerosis with the higher evolving risk. (December 2020) Authors: Jésus, P.; Fayemendy, P.; Sourisseau, H.; Lautrette, G.; Preux, P.M.; Couratier, P.; Desport, J.C. Journal: Clinical nutrition ESPEN Issue: Volume 40(2020) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗